Profile | GDS4284 / 229770_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 429.574 | 62 |
GSM687648 | Patient 402 control | 1057.27 | 75 |
GSM687653 | Patient 403 control | 297.645 | 57 |
GSM687658 | Patient 404 control | 1175.38 | 76 |
GSM687663 | Patient 411 control | 1798.77 | 83 |
GSM687668 | Patient 422 control | 981.197 | 74 |
GSM687673 | Patient 424 control | 1212.34 | 77 |
GSM687678 | Patient 425 control | 1257.14 | 77 |
GSM687683 | Patient 427 control | 842.806 | 71 |
GSM687688 | Patient 428 control | 415.209 | 61 |
GSM687695 | Patient 441 control | 10858.3 | 97 |
GSM687699 | Patient 443 control | 1642.46 | 81 |
GSM687704 | Patient 444 control | 527.703 | 64 |
GSM687707 | Patient 448 control | 180.264 | 42 |
GSM687712 | Patient 449 control | 534.564 | 64 |
GSM687719 | Patient 450 control | 1691.98 | 82 |
GSM687724 | Patient 451 control | 518.035 | 64 |
GSM687728 | Patient 452 control | 3620.87 | 91 |
GSM687646 | Patient 401 treated 24h | 255.694 | 52 |
GSM687649 | Patient 402 treated 24h | 1144.28 | 76 |
GSM687665 | Patient 411 treated 24h | 2428.56 | 86 |
GSM687651 | Patient 402 treated 4 weeks | 1388.43 | 78 |
GSM687667 | Patient 411 treated 4 weeks | 768.75 | 70 |
GSM687670 | Patient 422 treated 24h | 927.397 | 72 |
GSM687671 | Patient 422 treated 4 weeks | 768.686 | 70 |
GSM687654 | Patient 403 treated 24h | 377.436 | 60 |
GSM687675 | Patient 424 treated 24h | 1444.04 | 79 |
GSM687685 | Patient 427 treated 24h | 1192.35 | 76 |
GSM687656 | Patient 403 treated 4 weeks | 232.016 | 53 |
GSM687677 | Patient 424 treated 4 weeks | 853.652 | 71 |
GSM687687 | Patient 427 treated 4 weeks | 418.79 | 61 |
GSM687692 | Patient 428 treated 4h | 455.654 | 62 |
GSM687716 | Patient 449 treated 4h | 237.295 | 52 |
GSM687722 | Patient 450 treated 4h | 1518.64 | 80 |
GSM687680 | Patient 425 treated 24h | 953.856 | 73 |
GSM687690 | Patient 428 treated 24h | 588.29 | 67 |
GSM687700 | Patient 443 treated 24h | 5064.71 | 94 |
GSM687705 | Patient 444 treated 24h | 1771.52 | 82 |
GSM687714 | Patient 449 treated 24h | 661.179 | 68 |
GSM687721 | Patient 450 treated 24h | 2601.9 | 87 |
GSM687682 | Patient 425 treated 4 weeks | 980.269 | 74 |
GSM687694 | Patient 428 treated 4 weeks | 840.659 | 71 |
GSM687702 | Patient 443 treated 4 weeks | 830.53 | 71 |
GSM687718 | Patient 449 treated 4 weeks | 436.061 | 62 |
GSM687723 | Patient 450 treated 4 weeks | 716.624 | 69 |
GSM687661 | Patient 404 treated 4h | 869.258 | 72 |
GSM687710 | Patient 448 treated 4h | 381.646 | 60 |
GSM687726 | Patient 451 treated 4h | 467.398 | 62 |
GSM687730 | Patient 452 treated 4h | 5106.8 | 94 |
GSM687660 | Patient 404 treated 24h | 11333.4 | 97 |
GSM687697 | Patient 441 treated 24h | 7137.5 | 96 |
GSM687709 | Patient 448 treated 24h | 728.225 | 70 |
GSM687725 | Patient 451 treated 24h | 761.056 | 70 |
GSM687729 | Patient 452 treated 24h | 11453.5 | 97 |
GSM687727 | Patient 451 treated 4 weeks | 649.692 | 67 |
GSM687731 | Patient 452 treated 4 weeks | 3250.91 | 90 |